Role of syrup mefenamic acid or syrup paracetamol in preventing pain associated with vaccination in childre
Not Applicable
Completed
- Registration Number
- CTRI/2021/01/030239
- Lead Sponsor
- Dr Rachna Pasi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 135
Inclusion Criteria
Children who will be coming for routine vaccination as per National immunization schedule and whose parents will give written informed consent to participate in this study.
Exclusion Criteria
1.All children whose parents will not give consent to participate.
2.Children who will be having any liver or kidney diseases and coagulation disorders.
3.Children with past history of any allergic reactions.
4.Children in whom pain assessment could not be satisfactorily done
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the effect of mefenamic acid or paracetamol as prophylactic analgesic in pain management in children during vaccination using FLACC scale.Timepoint: At time of vaccination <br/ ><br>15 minutes after vaccination <br/ ><br>30 minutes after vaccination
- Secondary Outcome Measures
Name Time Method To assess the effect of mefenamic acid or paracetamol on systemic symptoms after vaccinationTimepoint: 24 hours after vaccination